The European Organisation for Research and Treatment of Cancer (EORTC) quality of life questionnaire for Japanese patients with bone metastases - The Japanese version of the EORTC QLQ-BM22

Japanese Journal of Cancer and Chemotherapy

Volumn 37, Issue 8, 2010, Pages 1507-1512

  Satoh, Takefumi ^a   Kobayashi, Kunihiko ^b   Hori, Taisuke ^c   Iida, Shinsuke ^d   Sato, Atsushi ^e   Ishiguro, Hiroshi ^f   Chow, Edward ^g   Shimozuma, Kojiro ^h  

^a KITASATO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b SAITAMA MEDICAL UNIVERSITY   (Japan)

^c Shiga Medical Center for Adults   (Japan)

^d NAGOYA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCES   (Japan)

^e SHOWA UNIVERSITY HOSPITAL   (Japan)

^f KYOTO UNIVERSITY HOSPITAL   (Japan)

^g DEPARTMENT OF RADIATION ONCOLOGY   (Canada)

^h RITSUMEIKAN UNIVERSITY   (Japan)

Author keywords

Bone metastasis; EORTC QLQ; Health related quality of life

Indexed keywords

ARTICLE; BONE METASTASIS; EUROPEAN ORGANIZATION FOR RESEARCH AND TREATMENT OF CANCER QUALITY OF LIFE QUESTIONNAIRE; HUMAN; JAPANESE; LANGUAGE; QUALITY OF LIFE; QUESTIONNAIRE; RATING SCALE;

EID: 79961118920     PISSN: 03850684     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Chow E and Bottomley A: Understanding the EORTC QLQ-BM22, the module for patients with bone metastases. Expert Rev Pharmacoecon Outcomes Res 9(5): 461-465, 2009.
2. Satoh T, Kimura M, Matsumoto K, et al: Single infusion of zoledronic acid to prevent androgen-deprivation therapy-induced bone loss in men with hormone-naïve prostate carcinoma. Cancer 115(15): 3468-3474, 2009.
3. Aaronson NK, Ahmedzai S, Bergman B, et al: The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 85(5): 365-376, 1993. (Pubitemid 23073154)
4. Cella DF, Tulsky DS and Gray G: The Functional Assessment of Cancer Therapy scale: development and validation of the general measure. J Clin Oncol 11(3): 570-579, 1993.
5. Ware JE Jr and Sherbourne CD: The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 30(6): 473-483, 1992.
6. Bergman B, Aaronson NK and Ahmedzai S: The EORTC QLQ-LC13:a modular supplement to the EORTC Core Quality of Life Questionnaire (QLQ-C30) for use in lung cancer clinical trials. EORTC Study Group on Quality of Life. Eur J Cancer 30A(5): 635-642, 1994.
7. Cella DF, Bonomi AE and Lloyd SR: Reliability and validity of the Functional Assessment of Cancer Therapy-Lung (FACT-L) quality of life instrument. Lung Cancer 12(3): 199-220, 1995.
8. Sprangers MA, Groenvold M and Arraras JI: The European Organization for Research and Treatment of Cancer breast cancer-specific quality-of-life questionnaire module: first results from a three-country field study. J Clin Oncol 14(10): 2756-2768, 1996. (Pubitemid 26329662)
9. Brady MJ, Cella DF and Mo F: Reliability and validity of the Functional Assessment of Cancer Therapy-Breast quality-of-life instrument. J Clin Oncol 15(3): 974-986, 1997. (Pubitemid 27106280)
10. Aaronson NK, Van Andel G, for the EORTC Genito Urinary Tract Cancer Group: An international field of the reliability and validity of the QLQ-C30 and a disease-specific questionnaire module (QLQ-PR25) for assessing quality of life of patients with prostate cancer. European Organization for Research and Treatment of Cancer study protocol (15011), Brussels, 2002.
11. Esper P, Mo F, Chodak G, et al: Measuring QOL in men with prostate cancer using the FACT-P instrument Urology 50(6): 920-928, 1997.
12. Chow E, Hird A, Velikova G, et al: European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire for patients with bone metastases: the EORTC QLQ-BM22. Eur J Cancer 45(7): 1146-1152, 2009.
13. Tubiana-Hulin M: Incidence, prevalence and distribution of bone metastases. Bone 12(suppl 1): S9-10, 1991.
14. Saad F, Gleason DM, Murray R, et al: A randomized, placebo-controlled trial of zoledronic acid in patients with hormone-refractory metastatic prostate carcinoma. J Natl Cancer Inst 94(19): 1458-1468, 2002.
15. Groenvold M, Petersen MA, Aaronson NK, et al: The development of the EORTC QLQ-C15-PAL: a shortened questionnaire for cancer patients in palliative care. Eur J Cancer 42(1): 55-64, 2006. (Pubitemid 41818953)
16. Aitken RCV: Measurement of feelings using visual analogue scales. Proc R Soc Med 62: 989-993, 1969.
17. Deschamps M, Band PR and Coldman AJ: Assessment of adult cancer pain: shortcomings of current methods. Pain 32(2): 133-139, 1988.
18. Whaley L and Wong D: Nursing care of infants and children, 3rd edition. St. Louis, Missouri, Mosby Year Book, 1987, p1070.